High suPAR levels predict risk of mortality during hospitalization in acute heart failure patients
Wed Mar 31 2021
Soluble urokinase-type plasminogen activator receptor strongly predicts global mortality in acute heart failure patients: insight from the STADE-HF registry
published in Future Science
The objective of this new study was to evaluate the prognosis performance of the biomarker suPAR on mortality and risk of readmission in acute heart failure patients.
Within the 95 patients included in the statistical analysis, the suPAR level was significantly higher in those who died at one month and one year, meaning that suPAR was proven to be highly predictive of the risk of mortality. There was no significant difference in readmission risk.
Heart failure is a major cause of hospitalization, morbidity, and mortality and thus an immense burden to healthcare systems.
Therefore, the outcomes of this study emphasize the importance of measuring suPAR in patients with suspected heart failure, to improve patient stratification.
High suPAR levels predict the risk of mortality in patients hospitalized for acute heart failure
– Huet et al, Future Science , March 2021
